CATALOGO DEI PRODOTTI DELLA RICERCA

BRUNELLI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.730
NA - Nord America 12.462
AS - Asia 5.836
SA - Sud America 96
AF - Africa 86
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 13
Totale 31.252
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.197
GB - Regno Unito 4.194
CN - Cina 3.698
IT - Italia 1.906
SG - Singapore 1.536
SE - Svezia 1.350
RU - Federazione Russa 1.125
IE - Irlanda 1.078
DE - Germania 933
FR - Francia 931
FI - Finlandia 664
CA - Canada 250
UA - Ucraina 206
BE - Belgio 109
KR - Corea 100
VN - Vietnam 94
JP - Giappone 84
TR - Turchia 74
HK - Hong Kong 64
TG - Togo 60
NL - Olanda 58
BR - Brasile 57
ID - Indonesia 28
IN - India 28
AU - Australia 26
IR - Iran 22
LT - Lituania 20
AT - Austria 19
ES - Italia 17
CL - Cile 13
CZ - Repubblica Ceca 13
LV - Lettonia 13
PL - Polonia 13
CH - Svizzera 11
EC - Ecuador 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
BG - Bulgaria 8
EU - Europa 8
IL - Israele 8
LK - Sri Lanka 8
TW - Taiwan 8
EG - Egitto 7
GR - Grecia 7
HU - Ungheria 7
MA - Marocco 7
MY - Malesia 7
PK - Pakistan 7
PT - Portogallo 7
AM - Armenia 6
IM - Isola di Man 6
KG - Kirghizistan 6
LA - Repubblica Popolare Democratica del Laos 6
PA - Panama 6
PE - Perù 6
AR - Argentina 5
DK - Danimarca 5
EE - Estonia 5
BD - Bangladesh 4
HR - Croazia 4
KE - Kenya 4
RO - Romania 4
SA - Arabia Saudita 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BO - Bolivia 3
CO - Colombia 3
JM - Giamaica 3
JO - Giordania 3
MT - Malta 3
MX - Messico 3
NZ - Nuova Zelanda 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
CM - Camerun 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
MK - Macedonia 2
NO - Norvegia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
A1 - Anonimo 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 31.252
Salva come PNG Salva come JPEG
Città #
Southend 3.738
Chandler 2.472
Jacksonville 1.328
Singapore 1.275
Dublin 1.068
Woodbridge 1.067
Ann Arbor 960
Beijing 734
Ashburn 688
Houston 447
Lawrence 367
Princeton 367
New York 350
Wilmington 345
Verona 334
Jinan 330
Helsinki 270
Nanjing 244
Shenyang 225
Munich 205
Montréal 195
Mcallen 179
Hebei 175
Sindelfingen 134
Dearborn 131
Tianjin 130
Milan 123
Zhengzhou 122
Redmond 118
Ningbo 105
Brussels 104
Seoul 97
Rome 96
Changsha 93
Taizhou 93
Boardman 91
Bologna 91
Seattle 91
Haikou 88
Santa Clara 85
Guangzhou 81
Nanchang 79
Redwood City 74
Tokyo 74
Taiyuan 69
Lancaster 66
Los Angeles 66
Jiaxing 65
Hangzhou 62
Lomé 60
Dong Ket 57
Hong Kong 55
Norwalk 51
Volga 47
Moscow 42
Dallas 40
Fairfield 38
Lanzhou 37
Kent 35
Washington 34
Chicago 33
Detroit 33
Toronto 31
Falls Church 29
Düsseldorf 28
Fuzhou 28
Jakarta 24
San Francisco 24
London 23
Bari 22
Shanghai 22
Dongguan 21
Frankfurt am Main 20
Amsterdam 19
Augusta 19
Vienna 19
Palermo 16
San Mateo 16
Lappeenranta 15
Cambridge 13
Bergamo 12
Newark 12
Ardabil 11
Ottawa 11
Wuhan 11
Clearwater 10
Isola della Scala 10
Perugia 10
Pozza 10
Qingdao 10
Bolzano 9
Catania 9
Riga 9
Stockholm 9
Turin 9
Chengdu 8
Colombo 8
Groningen 8
Kunming 8
Leawood 8
Totale 20.934
Salva come PNG Salva come JPEG
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 816
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 532
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 294
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 169
Schwannoma del rene 157
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 157
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 155
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 154
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 149
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 149
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 147
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 143
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 135
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 134
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 134
Chondroid syringoma with extensive ossification 131
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 127
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 126
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 125
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 123
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 123
L'ESPRESSIONE DI CITOCHERATINE E' IN ACCORDO CON LA DIFFERENZIAZIONE EPITELIALE DELLE NEOPLASIE RENALI HMB45 POSITIVE CON TRASLOCAZIONE T(6;11) 122
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 122
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 121
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 121
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 120
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 120
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 120
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 119
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 119
CD10 is expressed in a subset of chromophobe renal cell carcinomas 117
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 115
Utilità diagnostica di CD13 e CD10 nelle neoplasie a cellule renali 114
Subepithelial haematoma of the renal pelvis (Antopol-Goldman lesion) 114
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 113
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 113
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 112
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 112
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 112
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 112
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 112
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 111
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 111
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 110
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 110
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 109
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 109
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 108
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 108
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 108
HER2/neu Gene Determination in Women Screened for Breast Carcinoma: How Screening Programs Reduce the Skyrocketing Cost of Targeted Therapy 107
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 107
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 107
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 107
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 106
Pediatric optic nerve sheath meningioma 106
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 106
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 106
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 106
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 106
Espressione di CD23 nelle neoplasie cutanee annessiali 105
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 105
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 104
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 104
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 104
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 103
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 102
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 102
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 102
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 101
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 100
Rapid screening for malignancy in organ donors. 15 years experience with the Verona "Alert" protocol and review of the literature 100
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 99
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 99
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 99
Parvalbumin is constantly expressed in chromophobe renal carcinoma. 98
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 98
Adenocarcinoma of the paraurethral glands: a case report 98
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma 97
Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set 97
Ependymoma with diffuse signet-ring features: report of a case and review of the literature 97
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 97
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 97
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 97
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 96
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 96
High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy 96
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 96
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 96
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting 96
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 96
[Diagnostic and prognostic markers in renal tumors] 95
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 95
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 95
Clinical Factors Predicting Tumour Upgrading in Patients Under Active Surveillance and Elected to Active Treatment after Disease Reclassification or Progression 95
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 95
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 95
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 94
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 94
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 94
Totale 12.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.660
article - articoli 111.236
book - libri 0
conference - conferenze 12.184
curatela - curatele 0
other - altro 240
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 247.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.301 0 0 0 0 0 447 400 181 177 333 308 455
2020/20213.742 351 616 231 540 534 355 105 150 124 62 416 258
2021/20223.076 333 739 51 338 150 132 50 208 93 85 232 665
2022/20237.040 459 772 615 1.188 606 1.737 72 482 765 72 162 110
2023/20244.081 172 300 332 447 481 669 199 246 67 279 638 251
2024/20254.029 507 544 549 1.656 428 345 0 0 0 0 0 0
Totale 32.104